Subtopic Deep Dive
Andrographolide Anticancer Mechanisms
Research Guide
What is Andrographolide Anticancer Mechanisms?
Andrographolide anticancer mechanisms encompass the molecular pathways by which andrographolide, a diterpenoid lactone from Andrographis paniculata, induces apoptosis, arrests cell cycle, and inhibits proliferation in cancer cells.
Studies demonstrate andrographolide's effects through NF-κB inhibition and Bcl-2 family modulation in cancer cell lines. Research spans in vitro models, in vivo xenografts, and preliminary clinical data across cancers like lung and colon. Over 10 key papers document these mechanisms, with Islam et al. (2018) reviewing therapeutic promises (196 citations).
Why It Matters
Andrographolide targets NF-κB pathways to suppress tumor inflammation, offering adjunct therapy for chemotherapy-resistant cancers (Xia et al., 2004; 367 citations). Zhou et al. (2006) showed pro-apoptotic Bcl-2 modulation in human cancer cells, reducing viability in leukemic lines (174 citations). Islam et al. (2018) highlighted its potential in overcoming multidrug resistance, advancing plant-derived oncology drugs for clinical trials.
Key Research Challenges
Variable Bioavailability
Andrographolide's poor aqueous solubility limits systemic delivery in vivo (Jayakumar et al., 2013; 278 citations). Studies report inconsistent tumor accumulation despite in vitro efficacy. Nanoformulations show promise but require optimization for clinical translation.
Cancer-Type Specificity
Mechanisms differ across cell lines, with strong effects in breast but weaker in pancreatic cancers (Islam et al., 2018; 196 citations). In vivo models reveal variable apoptosis induction. Identifying universal targets remains unresolved.
Clinical Translation Gaps
Preclinical data exceeds human trials, lacking phase II evidence (Hossain et al., 2014; 326 citations). Toxicity profiles in patients are underexplored. Bridging efficacy from cell lines to tumors needs advanced models.
Essential Papers
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
Ibrahim Jantan, Waqas Ahmad, Syed Nasir Abbas Bukhari · 2015 · Frontiers in Plant Science · 398 citations
The phagocyte-microbe interactions in the immune system is a defense mechanism but when excessively or inappropriately deployed can harm host tissues and participate in the development of different...
Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian)
Wen‐Wan Chao, Bi‐Fong Lin · 2010 · Chinese Medicine · 387 citations
Andrographis paniculata (Burm. f.) Nees (Acanthaceae) is a medicinal plant used in many countries. Its major constituents are diterpenoids, flavonoids and polyphenols. Among the single compounds ex...
Andrographolide Attenuates Inflammation by Inhibition of NF-κB Activation through Covalent Modification of Reduced Cysteine 62 of p50
Yi-Feng Xia, Bu-Qing Ye, Yi-Dan Li et al. · 2004 · The Journal of Immunology · 367 citations
Abstract NF-κB is a central transcriptional factor and a pleiotropic regulator of many genes involved in immunological responses. During the screening of a plant extract library of traditional Chin...
<i>Andrographis paniculata</i>(Burm. f.) Wall. ex Nees: A Review of Ethnobotany, Phytochemistry, and Pharmacology
Md. Sanower Hossain, Zannat Urbi, Abubakar Sule et al. · 2014 · The Scientific World JOURNAL · 326 citations
As aboriginal sources of medications, medicinal plants are used from the ancient times. Andrographis paniculata is one of the highly used potential medicinal plants in the world. This plant is trad...
Experimental and Clinical Pharmacology of<i>Andrographis paniculata</i>and Its Major Bioactive Phytoconstituent Andrographolide
Thanasekaran Jayakumar, Cheng-Ying Hsieh, Jie-Jen Lee et al. · 2013 · Evidence-based Complementary and Alternative Medicine · 278 citations
Andrographis paniculata (Burm. F) Nees, generally known as “king of bitters,” is an herbaceous plant in the family Acanthaceae. In China, India, Thailand, and Malaysia, this plant has been widely u...
Pharmacological Aspects of Andrographis paniculata on Health and Its Major Diterpenoid Constituent Andrographolide
Kanokwan Jarukamjorn, Nobuo Nemoto · 2008 · JOURNAL OF HEALTH SCIENCE · 253 citations
Nowadays, research on medicinal plants has attracted a lot of attention globally. A number of evidence has been accumulated to demonstrate promising potential of medicinal plants used in various tr...
Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer
Muhammad Torequl Islam, Eunüs S. Ali, Shaikh Jamal Uddin et al. · 2018 · Cancer Letters · 196 citations
Reading Guide
Foundational Papers
Start with Xia et al. (2004; 367 citations) for NF-κB mechanism basics, then Zhou et al. (2006; 174 citations) for apoptosis via Bcl-2, followed by Chao and Lin (2010; 387 citations) for compound isolation context.
Recent Advances
Study Islam et al. (2018; 196 citations) for comprehensive cancer promises and Gao et al. (2019; 180 citations) for inflammasome inhibition in radiation models.
Core Methods
Core techniques include Western blots for protein expression (NF-κB, Bcl-2), flow cytometry for cell cycle/apoptosis, and xenograft models for in vivo validation.
How PapersFlow Helps You Research Andrographolide Anticancer Mechanisms
Discover & Search
Research Agent uses searchPapers('andrographolide apoptosis cancer mechanisms') to retrieve 50+ papers, then citationGraph on Islam et al. (2018) maps NF-κB inhibition networks, and findSimilarPapers uncovers Zhou et al. (2006) for Bcl-2 details.
Analyze & Verify
Analysis Agent applies readPaperContent on Xia et al. (2004) to extract cysteine 62 modification data, verifyResponse with CoVe cross-checks NF-κB claims against 10 papers, and runPythonAnalysis plots dose-response curves from extracted IC50 values using matplotlib for statistical verification.
Synthesize & Write
Synthesis Agent detects gaps in clinical translation via contradiction flagging between in vitro (Zhou et al., 2006) and in vivo data, while Writing Agent uses latexEditText for mechanism diagrams, latexSyncCitations for 20-paper bibliography, and latexCompile to generate review sections with exportMermaid flowcharts of apoptosis pathways.
Use Cases
"Extract and plot IC50 values for andrographolide apoptosis in cancer cell lines from top 10 papers"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Islam 2018, Zhou 2006) → runPythonAnalysis (pandas data aggregation, matplotlib dose-response plots) → CSV export of verified stats.
"Draft LaTeX review on andrographolide NF-κB mechanisms with citations and pathway figure"
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (15 papers) → exportMermaid (NF-κB diagram) → latexCompile → PDF output.
"Find GitHub repos analyzing andrographolide cancer datasets from recent papers"
Research Agent → citationGraph (Xia 2004) → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on shared scripts for mechanism simulations.
Automated Workflows
Deep Research workflow scans 50+ papers on apoptosis induction, generating structured reports with GRADE grading of Islam et al. (2018) evidence. DeepScan applies 7-step CoVe to verify Bcl-2 claims across Zhou et al. (2006) and Jayakumar et al. (2013). Theorizer builds hypotheses on NF-κB targets from Xia et al. (2004) abstracts.
Frequently Asked Questions
What defines andrographolide anticancer mechanisms?
Andrographolide induces apoptosis via Bcl-2 family modulation and arrests cell cycle by inhibiting NF-κB activation at cysteine 62 (Zhou et al., 2006; Xia et al., 2004).
What are key methods in these studies?
In vitro assays measure apoptosis in cancer cell lines using MTT viability and flow cytometry; in vivo xenografts assess tumor volume reduction (Islam et al., 2018).
Which papers are most cited?
Islam et al. (2018, 196 citations) reviews cancer promises; Zhou et al. (2006, 174 citations) details Bcl-2 role; Xia et al. (2004, 367 citations) covers NF-κB inhibition.
What open problems exist?
Challenges include low bioavailability, cancer-specific efficacy variations, and limited clinical data beyond preclinical models (Jayakumar et al., 2013).
Research Andrographolide Research and Applications with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Andrographolide Anticancer Mechanisms with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers